|
|
||||||||
The FASEB Journal, Vol 7, 369-374, Copyright © 1993 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
JA Corbett, MA Sweetland, JR Lancaster Jr and ML McDaniel
Department of Pathology, Washington University School of Medicine, St. Louis, Missouri 63110.
Nitric oxide has been implicated as the effector molecule that mediates interleukin-1 beta (IL-1 beta)-induced inhibition of glucose-stimulated insulin secretion by rat islets. Brief exposures of islets (1 h) to IL- 1 beta have been shown to inhibit glucose-stimulated insulin secretion at 8 or 18 h after removal of this cytokine. The purpose of this investigation was to determine if brief exposures of islets to IL-1 beta are sufficient to induce the formation of nitric oxide and to examine the signaling process associated with IL-1 beta-induced expression of nitric oxide synthase. We demonstrate that a 1-h pretreatment of islets with IL-1 beta followed by an 8-h incubation in the absence of this cytokine results in inhibition of glucose- stimulated insulin secretion (50%), which is completely prevented by pretreatment of islets with the nitric oxide synthase inhibitor NG- monomethyl-L-arginine (NMMA). The production of nitric oxide by islets under these pulse conditions is demonstrated by IL-1 beta-induced nitrite and electron paramagnetic resonance-detectable iron-nitrosyl complex formation, both of which are prevented by NMMA. IL-1 beta initiates a signal transduction process resulting in the expression of nitric oxide synthase. The signaling process appears to require the activation of a tyrosine kinase, since the tyrosine kinase inhibitor genistein prevents both IL-1 beta-induced inhibition of insulin secretion by islets and formation of nitric oxide by the insulinoma cell line RINm5F. These results show that short exposures of islets to IL-1 beta are sufficient to induce the formation of nitric oxide resulting in inhibition of glucose-stimulated insulin secretion and that a tyrosine kinase may participate in the early signaling events required for IL-1 beta to induce the expression of nitric oxide synthase.
This article has been cited by other articles:
![]() |
E. Bertelli and M. Bendayan Association between Endocrine Pancreas and Ductal System. More than an Epiphenomenon of Endocrine Differentiation and Development? J. Histochem. Cytochem., September 1, 2005; 53(9): 1071 - 1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kekuda, F. H. Leibach, T. C. Furesz, C. H. Smith, and V. Ganapathy Polarized Distribution of Interleukin-1 Receptors and Their Role in Regulation of Serotonin Transporter in Placenta J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1032 - 1041. [Abstract] [Full Text] |
||||
![]() |
P. M. Jones and S. J. Persaud Protein Kinases, Protein Phosphorylation, and the Regulation of Insulin Secretion from Pancreatic {beta}-Cells. Endocr. Rev., August 1, 1998; 19(4): 429 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Larsen, K. A. W. Wadt, L. F. Juhl, H. U. Andersen, A. E. Karlsen, M. S.-S. Su, K. Seedorf, L. Shapiro, C. A. Dinarello, and T. Mandrup-Poulsen Interleukin-1beta -induced Rat Pancreatic Islet Nitric Oxide Synthesis Requires Both the p38 and Extracellular Signal-regulated Kinase 1/2 Mitogen-activated Protein Kinases J. Biol. Chem., June 12, 1998; 273(24): 15294 - 15300. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vadakekalam, M. E. Rabaglia, and S. A. Metz Interleukin-1beta inhibits phospholipase C and insulin secretion at sites apart from KATP channel Am J Physiol Endocrinol Metab, November 1, 1997; 273(5): E942 - E950. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Feinstein, E. Galea, D. A. Aquino, G. C. Li, H. Xu, and D. J. Reis Heat Shock Protein 70Suppresses Astroglial-inducible Nitric-oxide Synthase Expression by Decreasing NFkappa B Activation J. Biol. Chem., July 26, 1996; 271(30): 17724 - 17732. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Welsh and N. Welsh Interleukin-1beta-induced Ceramide and Diacylglycerol Generation May Lead to Activation of the c-Jun NH(2)-terminal Kinase and the Transcription Factor ATF2 in the Insulin-producing Cell Line RINm5F J. Biol. Chem., April 5, 1996; 271(14): 8307 - 8312. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |